• CNBC
  • Aug 06, 2021

Novavax delays Covid vaccine emergency authorization submission to FDA until fourth quarter - CNBC

Novavax announced that it will delay the submission of its Covid-19 vaccine to the Food and Drug Administration for emergency use authorization until its fourth quarter. Shares of the biotechnology … [+987 chars]

More In business